Paratus Sciences

Series-A
paratussciences.com Biotech & Healthcare Boston, United States Founded 2021 11–50 employees
Total Funding $100M
Latest Round $100M Series-A
Last Announced Mar 8, 2023
Investors 6 Backers
Decision Makers 6 Available

About Paratus Sciences

We navigate evolutionary data to translate extreme biological adaptations into first-in-class medicines. Learn more about our process.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Boston, United States
Year Founded 2021
Team Size 11–50 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website paratussciences.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @youngricka
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $100,000,000 · Series-A

    Backed by ARCH Venture Partners

  2. Milestone

    Company founded

    Boston, United States

Investors & Backers

6
ARCH Venture Partners
Lead
Alexandria Venture Investments
ClavystBio
EcoR1 Capital
Leaps by Bayer
Polaris

Funding History

1 Round
Series-A equity · Mar 8, 2023

Round backers: ARCH Venture Partners

$100,000,000 startupintros.com

Founders & Leadership

4

Alicia Secor

President and CEO

Work email & phone locked Unlock →

Paul Matsudaira

Co-founder, Paratus

Work email & phone locked Unlock →

Richard Young

Co-founder, Paratus

Work email & phone locked Unlock →

Thomas Zwaka

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts